AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 3; Ask the Editor

Pancytopenia due to Radium-223 Treatment

A patient with prostate cancer and bone metastasis was admitted due to multiple medical conditions. During the admission, the provider documented that the patient had worsening pancytopenia, likely related to radium-223 treatments. When referencing “adverse effect” of “radioactive drugs NEC” in the Table of Drugs and Chemicals, subcategory T50.8X5, Adverse effects of diagnostic agents, is provided. However, radium-223 was administered as a therapeutic treatment for metastatic prostate cancer and is not considered a “diagnostic agent.” What are the appropriate code assignments for pancytopenia due to radium-223 treatments? ...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.